Article
Identifying inflammatory phenotypes to target mechanism-specific treatments in sepsis.
Cell reports. Medicine - 15 Nov 2022
Gómez Hernando, Anderko Renee R, Carcillo Joseph A
Abstract excerpt
A clinical trial by Leventogiannis et al.1 suggests that ferritin and HLA-DR monocyte receptor expression can identify septic patients with macrophage-activation-like syndrome (MALS), or immunoparalysis, and that targeting IL-1ra treatment with this strategy may improve outcomes.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
